Metopar Tablet (Metoclopramide 5mg/ Paracetamol 500mg)

Metopar Tablet

Metopar Tablet is a combination medicine which may be used for the symptomatic treatment of migraine headache. This medicine is not recommended for use in patients below 18 years of age.

Side effects

Major & minor side effects for Metopar Tablet
Allergic skin reaction
Gastric / Mouth Ulcer
Bloody and cloudy urine
Anemia
Fatigue
Dizziness
Abdominal pain
Convulsions (seizures)
Irregular heartbeat
Diarrhea
Restlessness
Breast pain and tenderness
Uses of Metopar Tablet
What is it prescribed for?
Migraine

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to metoclopramide, paracetamol, or any other inactive ingredients present in the formulation.
Analgesic Nephropathy (Kidney Disease)
This medicine is not recommended for use in patients suffering from kidney diseases associated with the excessive use of painkillers due to the increased risk of worsening of the patient’s condition.
Severe liver impairment
This medicine is not recommended for use in patients with severe liver diseases due to the increased risk of worsening of the patient’s condition.
Gastrointestinal disorders
This medicine is not recommended for use in patients with gastrointestinal disorders like gastrointestinal hemorrhage, mechanical obstruction, and gastrointestinal perforation due to the increased risk of worsening of the patient’s condition.
Epilepsy
This medicine is not recommended for use in patients with epilepsy due to the increased risk of worsening of the patient’s condition.
Pheochromocytoma
This medicine is not recommended for use in patients with conditions like pheochromocytoma due to an increase in the risk of hypertensive crisis (very severe increase in the blood pressure).

Warnings

Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
General warnings
Overdose
Read the label carefully before consuming this medicine to avoid overdosage. Overdose may result in liver damage. Seek emergency medical attention if an overdose of this medicine is suspected.
Liver Disease
This medicine should be used with extreme caution in patients suffering from liver function impairment or active liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Chronic Malnutrition
This medicine should be used with extreme caution in patients suffering from malnourishment due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Neuroleptic Malignant Syndrome (NMS)
Use of this medicine may cause Neuroleptic Malignant Syndrome which is characterized by hyperthermia (fever), muscle rigidity, and altered consciousness. Report to the doctor immediately if these symptoms appear. Discontinue the treatment with this medicine if the symptoms persist.
Depression
Use of this medicine may cause depression in patients with or without the prior history of depression. Any symptoms of change in behavior or suicidal thoughts should be informed to the doctor on priority. Discontinue the treatment with this medicine if the symptoms worsen.
Use in Children
This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.
Driving or Operating machinery
Use of this medicine may cause drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Dosage

Missed Dose
Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
N/A
Instructions
Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of nervous system side effects such as dizziness, drowsiness, and difficulty concentrating. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine
Carbamazepine
Phenytoin
Sodium Nitrite
Leflunomide
Prilocaine
Atropine
Chlorpromazine
Disease interactions
Alcoholism
This medicine should be used with extreme caution in patients with chronic alcohol use due to the increased risk of serious liver injuries. Close monitoring of liver function is recommended for such patients. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Liver Disease
This medicine should be used with extreme caution in patients with liver function impairment or active liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Report any symptoms such as nausea, fever, rashes, dark urine, etc. to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Gastrointestinal Disorders
This medicine is not recommended for use in patients with gastrointestinal disorders like mechanical bowel obstruction, bowel perforation, or gastrointestinal hemorrhage due to the increased risk of worsening of the patient’s condition. An alternative treatment option should be considered based on the clinical condition.
Parkinson’s disease
This medicine should be used with caution in patients with Parkinson’s disease due to an increase in the risk of parkinsonian-like symptoms such as akinesia, bradykinesia, tremors, pill-rolling motion, and postural abnormalities. These symptoms will usually appear within the first 6 months of the treatment and subside within 2 to 3 months after discontinuation of the treatment.
Food interactions
Information not available.
Lab interactions
5-HIAA Urine Test
You may get a false-positive result for this test while taking this medicine. It is advised that you inform the doctor and lab technician about all your current medicines including herbs and supplements before undergoing any lab tests.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.

General Instructions

Take this medicine exactly as prescribed by the doctor. Do not take in larger or smaller quantities than recommended. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.